EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Global cannabis regulations: Current scenario and the way ahead

Abhinav Kumar Singh, Vikesh Kumar Shukla, Navneet Sharma

Journal of Opioid Management · 2026

DOI: 10.5055/jom.0986 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Opioid Management, 2026. Verfasst von Abhinav Kumar Singh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Amity University, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Drug and Narcotic Control, Cannabis, Medical Marijuana, Legislation, Drug.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabis sativa is commonly known as cannabis or marijuana. It is a psychoactive drug. It has been in use for thousands of years for its medicinal and recreational properties. This article explores the regulatory frameworks governing cannabis and similar drugs in the United States (US), India, and Australia, highlighting key differences, exclusions, inclusions, and their status. In the US, cannabis is federally illegal under the Controlled Substances Act, but numerous states have legalized its use for medical and recreational purposes, creating a patchwork of laws that vary widely across the country. In India, cannabis remains largely prohibited under the Narcotic Drugs and Psychotropic Substances Act, 1985, though certain traditional uses, such as bhang, are permitted, and there are emerging efforts to explore its medicinal potential. Australia has legalized medical cannabis at the federal level, while recreational use remains illegal, except for its decriminalization in the Australian Capital Territory. The Preferred Reporting Items for Systematic reviews and Meta-Analyses methodology has been adopted to make the review more efficient. This study identifies key factors influencing regulatory decisions, including public opinion, medical research, and economic considerations. The United Nations Single Convention on Narcotic Drugs (1961) poses a regulatory challenge by requiring member states to prohibit cannabis production, distribution, and use, thereby creating conflicts with national laws that have legalized or decriminalized cannabis, and hindering international cooperation, trade, and research. By addressing these factors, regulators can create effective frameworks that minimize harms and maximize benefits. Understanding these complex regulatory environments is crucial for policymakers, healthcare professionals, and industry members. This research contributes to informed discussions on harm reduction, public health, and human rights, ultimately informing evidence-based policy decisions and future directions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug and Narcotic ControlCannabisMedical MarijuanaLegislation, DrugMarijuana UseHumansAustraliaUnited StatesIndiaGovernment RegulationPolicy Making

Substanzen

Medical Marijuana

Autor:innen und Institutionen

  • Amity University, Uttar Pradesh, India.
  • Amity University, Uttar Pradesh, India. ORCID: https://orcid.org/0000-0002-5499-5301.

Zitieren

APA

Singh, A. K., Shukla, V. K., & Sharma, N. (2026). Global cannabis regulations: Current scenario and the way ahead. Journal of Opioid Management. https://doi.org/10.5055/jom.0986

Vancouver

Singh AK, Shukla VK, Sharma N. Global cannabis regulations: Current scenario and the way ahead. Journal of Opioid Management. 2026. doi:10.5055/jom.0986

BibTeX
@article{Singh2026,
  author = {Singh, Abhinav Kumar and Shukla, Vikesh Kumar and Sharma, Navneet},
  title = {Global cannabis regulations: Current scenario and the way ahead},
  journal = {Journal of Opioid Management},
  year = {2026},
  doi = {10.5055/jom.0986}
}
Kostenlos starten →